The "Implantable Drug Delivery Devices - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Implantable Drug Delivery Devices was ...

CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, recently unveiled its significantly enhanced online ordering system. This latest update on the ...

The investigational new drug application for the nanoparticle drug SNB-101 has been cleared for small cell lung cancer ...

Scientists have taken a major step forward in tackling one of the greatest abiding challenges in chemistry, by learning how to program the self-assembly of molecules in such a way that the end result ...

A collaborative team has developed a new method to program molecular self-assembly predictably. Researchers created versatile ...

From established players to up-and-coming firms, Canada's pharmaceutical company landscape is diverse and dynamic. Canadian ...

Drug delivery describes the method and approach to delivering drugs or pharmaceuticals and other xenobiotics to their site of action within an organism, with the goal of achieving a therapeutic ...

Jan. 8, 2025 — A breakthrough in decoding the growth process of Hexagonal Boron Nitride (hBN), a 2D material, and its nanostructures on metal substrates could pave ...

The exosome therapies market is expected to experience significant growth due to increased interest in regenerative medicine, ...

Luo, Molbay, Chen, Horvath, Kadletz, Kick, Zhao et al., 2025: Deep Learning Powered Imaging of Nanocarriers Across Entire Mouse Bodies at Single-Cell Resolution. Nature Biotechnology. DOI: ...

SN BioScience today announced that its lead asset SNB-101 has received Investigational New Drug (IND) clearance from the U.S.

Scientists from Trinity College Dublin have taken a major step forwards in tackling one of the greatest abiding challenges in chemistry, by learning how to programme the self-assembly of molecules in ...